154.54
Finanzdaten der Charles River Laboratories International Inc-Aktie (CRL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
4.87%
1,032.13
|
984.17 | 1,002.55 | 1,009.76 | 1,026.12 |
|
2.47%
932.00
|
909.50 | 3,170.10 | 231.62 | 202.06 |
Benefits Costs and Expenses |
-
|
- | 3,956.88 | - | - |
Costs And Expenses |
2.47%
932.00
|
909.50 | 1,304.47 | 892.36 | 874.47 |
Operating Income/Loss |
34.10%
100.13
|
74.67 | -167.69 | 117.41 | 151.65 |
Income/Loss From Continuing Operations Before Tax |
4.87%
1,032.13
|
984.17 | -2,954.33 | 1,009.76 | 1,026.12 |
Income Tax Expense/Benefit |
85.40%
18.73
|
10.10 | -3.044 | 20.95 | 25.39 |
Income/Loss From Continuing Operations After Tax |
103.62%
52.69
|
25.88 | -213.75 | 70.30 | 94.26 |
|
103.62%
52.69
|
25.88 | -213.75 | 70.30 | 94.26 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | 1.204 | 0.978 | 4.093 |
Attributable To Noncontrolling Interest |
10.27%
0.367
|
0.409 | 0.748 | 0.638 | 0.18 |
Basic Average Shares |
3.02%
49.15
|
50.68 | -0.081 | 51.39 | 51.55 |
Diluted Average Shares |
3.02%
49.32
|
50.85 | -0.085 | 51.58 | 51.85 |
Basic Earnings Per Share |
112.00%
1.06
|
0.50 | -4.19 | 1.34 | 1.75 |
Diluted Earnings Per Share |
112.00%
1.06
|
0.50 | -4.17 | 1.33 | 1.74 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | 1.204 | 0.978 | 4.093 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):